Presentation is loading. Please wait.

Presentation is loading. Please wait.

iRNA-PseU: Identifying RNA pseudouridine sites

Similar presentations


Presentation on theme: "iRNA-PseU: Identifying RNA pseudouridine sites"— Presentation transcript:

1 iRNA-PseU: Identifying RNA pseudouridine sites
Wei Chen, Hua Tang, Jing Ye, Hao Lin, Kuo-Chen Chou  Molecular Therapy - Nucleic Acids  Volume 5, (January 2016) DOI: /mtna Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

2 Figure 1 Illustration to show the pseudouridine (Ψ) modification. Its formation is catalyzed by the Ψ synthase. Molecular Therapy - Nucleic Acids 2016 5, DOI: ( /mtna ) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

3 Figure 2 A comparison between predicted results of iRNA-PseU and experimental results on a 200-nt (from to ) genomic region of chromosome XII from S. cerevisiae. The top panel shows the probability values calculated by iRNA-PseU. The middle panel shows the experimental results determined by using the Pseudo-Seq technique, where the six known Ψ sites are highlighted with red rectangles.7 The dashed blue line shows the consistency between the predicted result and the experimental one. The lower panel shows the relative genomic coordinate. Molecular Therapy - Nucleic Acids 2016 5, DOI: ( /mtna ) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

4 Figure 3 A graphical illustration to show the performance of iRNA-PseU by means of the receiver operating characteristic curve. Molecular Therapy - Nucleic Acids 2016 5, DOI: ( /mtna ) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

5 Figure 4 An in-depth analysis into the contributions of three models: the orange histogram stands for the accuracy score obtained by the model trained based on the nucleotide density in identifying Ψ sites; the green one for that based on the nucleotide chemical properties; and the blue for that by combing the above two models. See the text for more explanation. Molecular Therapy - Nucleic Acids 2016 5, DOI: ( /mtna ) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

6 Figure 5 Schematic drawing to show how to use the flexible scaled window along an RNA sequence to collect the potential Ψ-site-containing sequence samples. Molecular Therapy - Nucleic Acids 2016 5, DOI: ( /mtna ) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

7 Figure 6 Schematic illustration to show the mirror image of (a) the 5’ RNA terminal segment, and (b) the 3’ RNA terminal segment. The symbol ⇔ represents a mirror, and the real RNA segment is colored in blue, while its mirror image in red. Molecular Therapy - Nucleic Acids 2016 5, DOI: ( /mtna ) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

8 Figure 7 A histogram to show the overall accuracy obtained by the proposed predictor in identifying Ψ site with different ξ values. The accuracy for H.sapiens or M. musculus reaches a peak when ξ = 10, while that for S. cerevisiae reaches a peak when ξ = 15. Molecular Therapy - Nucleic Acids 2016 5, DOI: ( /mtna ) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

9 Figure 8 Illustration to show the structure of paired nucleic acid residues. The left panel is the A-U pair bonded to each other with two hydrogen bonds; the right panel is the G-C pair with three hydrogen bonds. Molecular Therapy - Nucleic Acids 2016 5, DOI: ( /mtna ) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

10 Figure 9 A semi-screenshot for the top-page of the iRNA-PseU web-server at iRNA-PseU. Molecular Therapy - Nucleic Acids 2016 5, DOI: ( /mtna ) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

11 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

12 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

13 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

14 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

15 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

16 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

17 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

18 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

19 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

20 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

21 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

22 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

23 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

24 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

25 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

26 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

27 Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.37)
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions


Download ppt "iRNA-PseU: Identifying RNA pseudouridine sites"

Similar presentations


Ads by Google